Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2181304
Max Phase: Preclinical
Molecular Formula: C36H59N11O7
Molecular Weight: 757.94
Molecule Type: Protein
Associated Items:
ID: ALA2181304
Max Phase: Preclinical
Molecular Formula: C36H59N11O7
Molecular Weight: 757.94
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C36H59N11O7/c1-20(2)16-26(45-34(53)28-13-9-15-47(28)35(54)27(17-21(3)4)46-31(50)23(37)19-29(38)48)33(52)43-24(12-8-14-42-36(40)41)32(51)44-25(30(39)49)18-22-10-6-5-7-11-22/h5-7,10-11,20-21,23-28H,8-9,12-19,37H2,1-4H3,(H2,38,48)(H2,39,49)(H,43,52)(H,44,51)(H,45,53)(H,46,50)(H4,40,41,42)/t23-,24-,25-,26-,27-,28-/m0/s1
Standard InChI Key: HXUIOTWFFCZTGT-QUQVWLGBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 757.94 | Molecular Weight (Monoisotopic): 757.4599 | AlogP: -1.80 | #Rotatable Bonds: 22 |
Polar Surface Area: 310.81 | Molecular Species: BASE | HBA: 9 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.83 | CX Basic pKa: 11.58 | CX LogP: -2.50 | CX LogD: -4.56 |
Aromatic Rings: 1 | Heavy Atoms: 54 | QED Weighted: 0.04 | Np Likeness Score: -0.04 |
1. Nichols R, Bass C, Demers L, Larsen B, Li E, Blewett N, Converso-Baran K, Russell MW, Westfall MV.. (2012) Structure-activity studies of RFamide-related peptide-1 identify a functional receptor antagonist and novel cardiac myocyte signaling pathway involved in contractile performance., 55 (17): [PMID:22909119] [10.1021/jm300760m] |
Source(1):